Published in Arch Intern Med on November 10, 2008
Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis (2013) 3.82
Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care (2010) 2.40
Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24
Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension (2010) 1.81
Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease. Br J Gen Pract (2012) 1.43
Awareness of chronic kidney disease among patients and providers. Adv Chronic Kidney Dis (2010) 1.42
Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol (2011) 1.39
Quality of patient-physician discussions about CKD in primary care: a cross-sectional study. Am J Kidney Dis (2010) 1.38
Validation of CKD and related conditions in existing data sets: A systematic review. Am J Kidney Dis (2010) 1.26
Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. Ann Fam Med (2011) 1.20
Dietary acid load: a novel nutritional target in chronic kidney disease? Adv Chronic Kidney Dis (2013) 1.15
Challenges perceived by primary care providers to educating patients about chronic kidney disease. J Ren Care (2012) 1.12
Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006). Environ Health Perspect (2010) 1.12
Comparison of CKD awareness in a screening population using the Modification of Diet in Renal Disease (MDRD) study and CKD Epidemiology Collaboration (CKD-EPI) equations. Am J Kidney Dis (2011) 1.04
Electronic health records: a new tool to combat chronic kidney disease? Clin Nephrol (2013) 1.03
Associations between access to care and awareness of CKD. Am J Kidney Dis (2012) 1.00
Access to health care among adults evaluated for CKD: findings from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2012) 0.99
State medicaid coverage, ESRD incidence, and access to care. J Am Soc Nephrol (2014) 0.99
Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based study. Nephrol Dial Transplant (2011) 0.95
A risk score for chronic kidney disease in the general population. Am J Med (2012) 0.93
Diabetic Cardiovascular Disease Predicts Chronic Kidney Disease Awareness in the Kidney Early Evaluation Program. Cardiorenal Med (2011) 0.93
Educating Patients about CKD: The Path to Self-Management and Patient-Centered Care. Clin J Am Soc Nephrol (2015) 0.92
Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J (2013) 0.92
Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease). PLoS One (2014) 0.90
Prevalence and Correlates of CKD in Hispanics/Latinos in the United States. Clin J Am Soc Nephrol (2015) 0.89
Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? Am J Nephrol (2012) 0.89
Mid-adulthood risk factor profiles for CKD. J Am Soc Nephrol (2014) 0.86
Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA. Clin Kidney J (2015) 0.86
Primary care physicians' familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study. BMC Nephrol (2014) 0.85
Americans' use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis (2013) 0.83
Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol (2013) 0.82
Epidemiology of chronic kidney disease in northern region of Senegal: a community-based study in 2012. Pan Afr Med J (2014) 0.81
Variation in Patients' Awareness of CKD according to How They Are Asked. Clin J Am Soc Nephrol (2016) 0.80
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study. KI Rep (2017) 0.80
Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland. Clin J Am Soc Nephrol (2015) 0.79
Pitfalls in diagnosing chronic kidney disease from eGFR. Arch Intern Med (2009) 0.79
Hypertension: the message of World Kidney Day 2009. Nat Rev Nephrol (2009) 0.79
Development of a chronic kidney disease patient navigator program. BMC Nephrol (2015) 0.78
Predictors of patient self-report of chronic kidney disease: baseline analysis of a randomised controlled trial. BMC Fam Pract (2014) 0.78
Cyclosporine A protects podocytes by regulating WAVE1 phosphorylation. Sci Rep (2015) 0.78
Prevalence of chronic kidney disease and associated factors in senegalese populations: a community-based study in saint-louis. Nephrourol Mon (2014) 0.78
National Kidney Foundation's Kidney Early Evaluation Program (KEEP) annual data report 2011: executive summary. Am J Kidney Dis (2012) 0.78
Chemical analog-to-digital signal conversion based on robust threshold chemistry and its evaluation in the context of microfluidics-based quantitative assays. J Am Chem Soc (2013) 0.77
Occupational exposure to respirable crystalline silica and chronic non-malignant renal disease: systematic review and meta-analysis. Int Arch Occup Environ Health (2017) 0.77
A pilot trial of a computerized renal template note to improve resident knowledge and documentation of kidney disease. Appl Clin Inform (2013) 0.76
Epidemiology of chronic kidney disease among normotensives: but what is chronic kidney disease? Hypertension (2010) 0.76
Development and validation of a self-assessment tool for albuminuria: results from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2011) 0.76
A Case for Early Screening for Diabetic Kidney Disease. Cardiorenal Med (2011) 0.76
Value of laboratory tests in employer-sponsored health risk assessments for newly identifying health conditions: analysis of 52,270 participants. PLoS One (2011) 0.75
The impact of moderate to severe renal insufficiency on patients with acute myocardial infarction. Korean Circ J (2011) 0.75
It takes a spark to light a fire: kindling interest in nephrology careers. J Am Soc Nephrol (2014) 0.75
Inpatients' awareness of admission reasons and management plans of their clinical conditions at a tertiary hospital in South Africa. BMC Health Serv Res (2015) 0.75
Costs of care at the end of life among elderly patients with chronic kidney disease: patterns and predictors in a nationwide cohort study. BMC Nephrol (2017) 0.75
Validation of an Albuminuria Self-assessment Tool in the Multi-Ethnic Study of Atherosclerosis. Ethn Dis (2015) 0.75
Chronic kidney disease: identification and management in primary care. Pragmat Obs Res (2016) 0.75
Global cardiovascular protection in chronic kidney disease. Nat Rev Cardiol (2016) 0.75
A lower baseline glomerular filtration rate predicts high mortality and newly cerebrovascular accidents in acute ischemic stroke patients. Medicine (Baltimore) (2017) 0.75
Telehealth Applications to Enhance CKD Knowledge and Awareness Among Patients and Providers. Adv Chronic Kidney Dis (2017) 0.75
Non-dialysis dependent chronic kidney disease is associated with high total and out-of-pocket healthcare expenditures. BMC Nephrol (2017) 0.75
End-Stage Renal Disease Outcomes among the Kaiser Permanente Southern California Creatinine Safety Program (Creatinine SureNet): Opportunities to Reflect and Improve. Perm J (2017) 0.75
Independent correlates of chronic kidney disease awareness among adults with type 2 diabetes. J Diabetes Complications (2017) 0.75
Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study. BMC Nephrol (2016) 0.75
Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study. BMC Nephrol (2017) 0.75
Genetic risk score and risk of stage 3 chronic kidney disease. BMC Nephrol (2017) 0.75
Chronic kidney disease: Automated eGFR reporting: good for the patient? Nat Rev Nephrol (2009) 0.75
Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans. BMC Nephrol (2017) 0.75
Estimation of daily protein intake based on spot urine urea nitrogen concentration in chronic kidney disease patients. Clin Exp Nephrol (2015) 0.75
Evaluation of the Scored Questionnaire to Identify Individuals with Chronic Kidney Disease in a Community-based Screening Program in Rural North Carolina. J Community Med Health Educ (2014) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care (2006) 12.14
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33
Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol (2004) 5.23
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol (2002) 3.48
Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc (2007) 3.22
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol (2003) 2.95
Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl (2003) 2.20
CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis (2006) 1.45
Prevalence and characteristics of a family history of end-stage renal disease among adults in the United States population: Reasons for Geographic and Racial Differences in Stroke (REGARDS) renal cohort study. J Am Soc Nephrol (2007) 1.40
Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis (2004) 1.32
Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007. Am J Nephrol (2007) 1.05
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med (2003) 23.33
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis (2003) 15.00
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med (2010) 13.25
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int (2005) 10.42
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med (2004) 10.35
Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med (2013) 9.87
MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet (2008) 9.50
Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med (2003) 9.29
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol (2006) 8.61
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol (2004) 8.21
Chronic kidney disease: global dimension and perspectives. Lancet (2013) 8.16
Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med (2013) 7.98
Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. Am J Kidney Dis (2007) 7.86
Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med (2011) 7.81
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol (2006) 7.51
Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet (2008) 7.31
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis (2002) 7.03
Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer (2008) 6.96
Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA (2005) 6.89
Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (2003) 6.85
Race and trust in the health care system. Public Health Rep (2003) 6.74
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89
Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health (2004) 5.79
Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes? J Urol (2008) 5.70
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med (2003) 5.47
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int (2011) 5.47
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
Chronic kidney disease. Lancet (2011) 5.42
The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med (2002) 5.33
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med (2013) 5.28
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet (2012) 5.10
Cultural competence: a systematic review of health care provider educational interventions. Med Care (2005) 5.09
Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis (2007) 5.06
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA (2003) 4.81
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation (2011) 4.78
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet (2012) 4.75
Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med (2007) 4.58
Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA (2004) 4.54
Clinical information technologies and inpatient outcomes: a multiple hospital study. Arch Intern Med (2009) 4.50
Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med (2007) 4.43
Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34